Cfo4 Life Group, LLC Charles River Laboratories International, Inc. Transaction History

Cfo4 Life Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$351.38 - $448.68 $799,389 - $1.02 Million	-2,275 Closed	0 $0
Q3 2021 Oct 12, 2021	SELL	$372.64 - $458.3 $23,476 - $28,872	-63 Reduced 2.69%	2,275 $939,000
Q2 2021 Jul 14, 2021	BUY	$294.17 - $371.65 $2,059 - $2,601	7 Added 0.3%	2,338 $865,000
Q1 2021 Apr 20, 2021	SELL	$249.67 - $299.48 $16,727 - $20,065	-67 Reduced 2.79%	2,331 $676,000
Q4 2020 Jan 12, 2021	SELL	$222.0 - $252.62 $23,088 - $26,272	-104 Reduced 4.16%	2,398 $599,000
Q3 2020 Oct 13, 2020	BUY	$175.56 - $226.45 $87,780 - $113,225	500 Added 24.98%	2,502 $567,000
Q2 2020 Jul 15, 2020	SELL	$118.84 - $189.72 $77,008 - $122,938	-648 Reduced 24.45%	2,002 $349,000
Q1 2020 Apr 16, 2020	BUY	$98.9 - $178.34 $262,085 - $472,601	2,650 New	2,650 $334,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Cfo4 Life Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Cfo4 Life Group, LLC with notifications on news.